These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37040726)

  • 41. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F; Albertsson-Wikland K; Wollmann HA; Chatelain P; Chaussain JL; Löfström A; Jonsson B; Rosenfeld RG
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone treatment in short children born prematurely--data from KIGS.
    Boguszewski MC; Karlsson H; Wollmann HA; Wilton P; Dahlgren J
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1687-94. PubMed ID: 21430029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely-Data From KIGS.
    Boguszewski MCS; Carlsson M; Lindberg A; Dahlgren J; Aydin F; Camacho-Hübner C; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32479603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty.
    Wu D; Chen RM; Chen SK; Liu GL; Chen LQ; Yang Y; Wang XL; Peng YG; Gong CX
    BMC Pediatr; 2020 Mar; 20(1):138. PubMed ID: 32222149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R; Saenger P; Wajnrajch MP;
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study.
    Juul A; Backeljauw P; Højby M; Kawai M; Kildemoes RJ; Linglart A; Zuckerman-Levin N; Horikawa R
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age.
    Juul A; Backeljauw P; Cappa M; Pietropoli A; Kelepouris N; Linglart A; Pfäffle R; Geffner M
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1043-1052. PubMed ID: 36469726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
    Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
    Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fat distribution in short-stature children born small for gestational age.
    Maeyama T; Ida S; Onuma S; Shoji Y; Yamamoto T; Etani Y; Kawai M
    Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D; Léger J; Carel JC
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W; Bannink E; van Dijk M; Willemsen R; van der Kaay D; de Ridder M; Hokken-Koelega A
    Horm Res; 2008; 69(2):89-98. PubMed ID: 18059089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.
    Fujita K; Nagasaka M; Iwatani S; Koda T; Kurokawa D; Yamana K; Nishida K; Taniguchi-Ikeda M; Uchino E; Shirai C; Iijima K; Morioka I
    Pediatr Int; 2016 May; 58(5):372-6. PubMed ID: 26617415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience.
    Karacan Küçükali G; Keskin M; Aycan Z; Savaş-Erdeve Ş; Çetinkaya S
    Eur J Med Genet; 2023 Oct; 66(10):104828. PubMed ID: 37673300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
    van der Steen M; Lem AJ; van der Kaay DC; Bakker-van Waarde WM; van der Hulst FJ; Neijens FS; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.